SCHEMBL24446243

SCHEMBL24446243

Brc1cc2c3ccccc3n(-c3ccccc3)c2s1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.55
▸ ATM Q13315 2/20 0.55
▸ KDM4E B2RXH2 2/20 0.55
▸ HSD17B10 Q99714 2/20 0.38
▸ KMT2A Q03164 4/20 0.36
▸ MAPK8 P45983 2/20 0.36
▸ IL1R1 P14778 1/20 0.36
▸ MAPK1 P28482 1/20 0.35
▸ PGR P06401 1/20 0.35
▸ ALDH1A1 P00352 5/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ MAPK9 P45984 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ KDR P35968 1/20 0.35
▸ GAA P10253 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ BRCA1 P38398 1/20 0.34
▸ FOLH1 Q04609 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23642495 0.80 KDM4E (0.55) L3MBTL1ATMKDM4EHSD17B10KMT2A
SCHEMBL22924446 0.78 KDM4E (0.52) L3MBTL1ATMKDM4EHSD17B10KMT2A
SCHEMBL22650892 0.77 FDPS (0.35) L3MBTL1ATMKDM4EHSD17B10MAPK1
SCHEMBL12483874 0.77 L3MBTL1 (0.55) L3MBTL1ATMKDM4EHSD17B10KMT2A
SCHEMBL8504030 0.76 KDM4E (0.51) L3MBTL1ATMKDM4EHSD17B10KMT2A
SCHEMBL22650889 0.74 L3MBTL1 (0.61) L3MBTL1ATMKDM4EHSD17B10KMT2A
SCHEMBL28558603 0.74 L3MBTL1 (0.47) L3MBTL1ATMKDM4EHSD17B10KMT2A
SCHEMBL24442023 0.73 KDM4E (0.39) KDM4EKMT2AALDH1A1MEN1MAPT
SCHEMBL31962 0.73 L3MBTL1 (1.00) L3MBTL1ATMKDM4EKMT2AMAPK8
Benzene SCHEMBL28486033 0.73 L3MBTL1 (1.00) L3MBTL1ATMKDM4EKMT2AMAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002419-A1 NOVEL BORON COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING SAME SFC CO., LTD. (KR) 2023-01-05 — — US disclosed
EP-4001284-A1 NOVEL BORON COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME SFC Co., Ltd. (KR) 2022-05-25 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002419-A1 NOVEL BORON COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING SAME CLTB, CD79B, RB1 L3MBTL1 202/4885ATM 1623/4885KDM4E 3307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback